Solar photovoltaic assistance for LHB rail coaches

Awareness for the need of sustainable and eco-friendly mobility has been increasing and various innovations are taking place in this regard. A study was carried out to assess the feasibility of installing solar photovoltaic (PV) modules atop train coaches. Most long-distance trains having LHB coaches do not have self-generating systems, thus making power cars mandatory to supply the required power for lighting loads. Feasibility of supplementing diesel generator sets with power from solar PV modules installed on coach rooftops has been reported in this communication. Not only is there a conservation of fuel, there is also a significant reduction in CO2 emissions. This work has shown that the area available on coach rooftops is more than sufficient to generate the required power, during sunlight hours, for the electrical loads of a non-A/C coach even during winter. All calculations were done keeping a standard route as the reference. Taking the cost of diesel to be Rs 66/litre, it was estimated that there will be annual savings of Rs 5,900,000 corresponding to 90,800 litres diesel per rake per year by implementing this scheme. The installation cost of solar modules would be recovered within 2-3 years. Implementation of this scheme would also amount to an annual reduction of 239 tonnes of CO2 emissions.

A Brief Overview of the Recent Bio-Medical Applications of Fiber Bragg Grating Sensors

Fiber Bragg Grating (FBG) sensors have become one of the most widely used sensors in the recent times for a variety of applications in the fields of aerospace, civil, automotive, etc. It has been recently realized that FBGs and etched FBGs can play an important role in biomedical applications. This article provides a brief overview of the recent advancements in the application of FBG sensors in bio-mechanical, bio-sensing and bio-medical fields.

Understanding Medical Device Patenting and Clinical Trials for Product Leadership

Unmet clinical needs remain the primary driving force for innovations in medical devices. While appropriate mechanisms to protect these innovative outcomes are essential, the performance of clinical trials to ensure safety is also mandated before the invention is ready for public use. Literature explaining the relationship between patenting activities and clinical trials of medical devices is scarce. Linking patent ownership to clinical trials may imply product leadership and value chain control. In this paper, we use patent data from Indian Patent Office (IPO), PCT, and data from Clinical Trials Registry of India (CTRI) to identify whether patent assignees have any role in leading as primary sponsors of clinical trials. A total of 42 primary sponsors are identified from the CTRI database in India. Number of patents awarded to these primary sponsors in the particular medical device, total number of patents awarded to the primary sponsor in all technologies, total number of patents in the specific medical device technology provides an indication of leadership and control in the value chain.